SOLANA BEACH, Calif. - Artelo Biosciences , Inc. (NASDAQ:ARTL), a clinical-stage biopharmaceutical company with a market capitalization of $4.5 million, announced nonclinical results for its ...
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
Artelo Biosciences (ARTL) announced nonclinical results on ART12.11, its proprietary cocrystal composition of cannabidiol and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback